Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Heitjan

Showing results (121-130 of 123) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 123 results.
Autophagy|July 4, 2014
Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanomaReshma Rangwala, Yunyoung C Chang, Janice Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responsesDaniel H Sterman, Adri Recio, Richard G Carroll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2016
Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with ChemotherapyDaniel H Sterman, Evan Alley, James P Stevenson, et al.
Pageof 13

Showing results (121-130 of 123) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 123 results.
Autophagy|July 4, 2014
Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanomaReshma Rangwala, Yunyoung C Chang, Janice Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responsesDaniel H Sterman, Adri Recio, Richard G Carroll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2016
Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with ChemotherapyDaniel H Sterman, Evan Alley, James P Stevenson, et al.
Pageof 13